Xelstrym

Active Ingredient(s): Dextroamphetamine
FDA Approved: * March 22, 2022
Pharm Company: * NOVEN PHARMS INC
Category: ADD / ADHD

Dextroamphetamine (D-AMP)[note 1] is a central nervous system (CNS) stimulant and an amphetamine enantiomer[note 2] that is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy.[17][18] It is also used as an athletic performance and cognitive enhancer, and recreationally as an aphrodisiac and euphoriant. Dextroamphetamine was also used in the past by some countries' military forces to fig... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Xelstrym 4.5 mg Transdermal Patch, Extended Release
NDC: 68968-0205
Labeler:
Noven Therapeutics, LLC
Xelstrym 9 mg Transdermal Patch, Extended Release
NDC: 68968-0210
Labeler:
Noven Therapeutics, LLC
Xelstrym 13.5 mg Transdermal Patch, Extended Release
NDC: 68968-0215
Labeler:
Noven Therapeutics, LLC
Xelstrym 18 mg Transdermal Patch, Extended Release
NDC: 68968-0220
Labeler:
Noven Therapeutics, LLC

Related Brands

Drugs with the same active ingredients